Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.50
+0.89993.98%
Volume:2K
Turnover:39.59K
Market Cap:4.70M
PE:- -
High:23.62
Open:23.49
Low:23.44
Close:22.60
52wk High:24.74
52wk Low:15.67
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.85
T/O Rate:0.84%
Dividend:0.77
Dividend Rate:3.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Oct 09

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Oct 09

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Oct 09

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Oct 09

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Oct 09

Learn Why The Bull Case For Moderna Stock Could Change Following COO Appointment

Simply Wall St.
·
Oct 09

Iambic Therapeutics Sets IPO Price Range at $15-$17 per Share to Raise $150 Million

Stock News
·
Oct 09

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
Oct 09

Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine

Reuters
·
Oct 09

RBC Capital Remains a Hold on Moderna (MRNA)

TIPRANKS
·
Oct 09

Trading DAY-the pAIn Trade Strikes

Reuters
·
Oct 09

Lilly’s Oral Orforglipron Trial Targets Early Obesity Risks, Raising the Stakes in Weight-Loss Pharma

TIPRANKS
·
Oct 09

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 09

Cboe data shows mixed options sentiment in Moderna with shares down 0.56%

TIPRANKS
·
Oct 08

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08

Jefferies Initiates Twist Bioscience at Hold With $150 Price Target

MT Newswires Live
·
Oct 08

How to invest in healthcare stocks without picking the next Eli Lilly

Simply Wall St.
·
Oct 08

Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

Benzinga Earnings
·
Oct 08

Twist Bioscience Corporation : Jefferies Initiates Coverage with Hold Rating; Target Price $150

THOMSON REUTERS
·
Oct 08

Trading DAY-Stocks, Bonds in Delicate Dance

Reuters
·
Oct 08